Fig. 2From: Influence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomesInfluence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomes. Number of topical medications (ordinate [n]) over time (abscissa [time after surgery]) from eyes classified as OAG, given separately for eyes without SLT treatment prior to surgery (black) and eyes who had insufficient response to 360° SLT treatment previous to surgery (grey). Data of number of antiglaucoma medications are presented as mean value and standard deviation preoperatively and at postoperative 1 day, 6 weeks, 3, 6, 12 and 24 months after surgeryBack to article page